Regional Scientific Director, Central Region

Intellia Therapeutics, Inc.•Cambridge, CO

1d•$216,000 - $264,000•Remote

About The Position

The Regional Scientific Director (Associate Director level) serves in a customer-facing medical role to establish trusted partnerships within the healthcare community covering Intellia’s CRISPR-based, first-in-class gene editing programs. Key responsibilities include scientific exchange, medical education and insight identification with PIs, KOLs, healthcare multidisciplinary teams and referral HCPs. RSDs will support both the nex-z and lonvo-z programs. Central region will include: Kansas, Nebraska, Colorado, Utah, Wyoming, Kansas City

Requirements

Demonstrated success working in a highly matrixed, cross-functional environment.
Ability to critically assess situations to prioritize the importance, urgency and risks, and present leadership with recommendations.
Ability to anticipate change and to flexibly adapt to changing business needs.
Self-starter and team player with a collaborative spirit and results orientation.
Organized, able to multi-task to meet timelines in a fast-paced environment with strong attention to accuracy and detail.
Excellent presentation, communication, and project management skills across a variety of interaction mediums including in person, digital, email, phone, etc.
Ability to understand and clearly and effectively communicate complex scientific and medical information to both internal and external stakeholders.
Excellent written and oral communication skills are imperative; strong interpersonal skills commensurate with the need to collaborate closely with partners, investigators, contractors, consultants, and team members across functions.
Established track record of effective and influential oral presentations to both large and small audiences within the healthcare profession.
Ability to complete required training, documentation, expense reporting, and other administrative tasks.
Willingness and ability to travel 50-70% including overnight stays.
Ability to manage a geographically assigned territory from a home-based office.
Computer skills including Excel, Word, Power Point, Outlook, and programs such as Zoom are expected.
Valid driver’s license
Doctorate level or terminal degree (Pharm.D., Ph.D., M.D. or D.O.)
3+ years industry or related field experience.
Extensive clinical trial experience including Phase 3 trials
Prior pharmaceutical industry experience as a MSL/RSD with solid understanding of scientific exchange in the context of compliance/ regulated environment and robust experience supporting execution of clinical trial.

Nice To Haves

Therapeutic knowledge in allergy/immunology/HAE, cardiology/ATTR-CM/-PN, or genetic medicine highly preferred.
New product launch experience highly preferred.

Responsibilities

Engagement with KOLs across ATTR amyloidosis and HAE within territory to provide education on our CRISPR gene editing platform and reactively educate on the MoA and clinical data on nex-z and lonvo-z.
Understanding of patient journey at key centers and identification of site capabilities and preferences regarding gene editing.
Development of individualized scientific engagement plans for key KOLs aligned with scientific narrative and medical strategy.
Identify external insights and knowledge gaps through listening for key intelligence topics of interest and timely reporting via CRM
Medical Congress attendance to enable KOL engagement, medical booth staffing, scientific session coverage, insights gathering and reporting
Institutional presentations on Intellia scientific evidence, as appropriate.
Provide scientific support for Phase 3 clinical trials during site start up, activation and recruitment through scientific education and operational insights
Establish, cultivate, and maintain scientific relationships with Investigators and study site teams
Identify barriers to site activation and/or patient recruitment, and discuss solutions with Investigators, study site teams, and institutional administrative team members to address and remove these barriers.
Escalate site feedback or concerns to Intellia clinical teams
Develop a robust understanding of clinical practice and referral associated with gene editing therapies.
Ensure compliance and high level of scientific integrity in all interactions, including completion of trainings on time and adherence to policies